Georgia's drug scene: what is happening on the black market, and how well does drug policy work?
Georgia's drug market has changed significantly in recent years. Alongside traditional opioids, synthetic substances and stimulants now play a much larger role.
Georgia's drug scene is no longer uniform
Talking about drugs in Georgia only in terms of heroin, cannabis or any single substance is no longer enough. Over recent decades the market has diversified, and official statistics — much of which concern injecting use — do not capture everyone affected.
What is sold on the black market?
There is no single, regularly updated database of sales, use, seizures, hospitalisations and deaths, so an exact “ranking” is hard to build. Research still points to several trends:
- Opioids — historically one of the most significant problem categories, including heroin and pharmaceutical opioids.
- Stimulants — amphetamine-type and other synthetic stimulants.
- Cannabis — widely used, with a different risk profile from high-risk opioids.
- New psychoactive substances — appear quickly, often with unknown effects and toxicity.
- Pharmaceuticals — non-medical use of prescription medicines.
The most dangerous is not always the most common
How widespread a substance is and how dangerous it is are different measures. Synthetic opioids show how quickly overdose risk can change.
What does the state do?
Georgia's drug policy is not limited to criminal law: opioid substitution therapy and harm-reduction programmes also operate across the country.
Where are the weak points?
- Fragmented data
- New psychoactive substances
- Poly-drug use
- Access to treatment
- The scale of harm reduction
Conclusion
The main challenge of Georgia's drug scene is how fast it changes. Policy should be judged not only by arrests, but by deaths prevented, access to treatment and the speed at which new risks are detected.
This English version is a summary. The full article is available in Georgian.